SenesTech (NASDAQ:SNES) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock.

Separately, HC Wainwright restated a “buy” rating and issued a $3.50 price objective on shares of SenesTech in a research report on Tuesday, May 14th.

SenesTech Stock Performance

Shares of NASDAQ SNES opened at $0.57 on Wednesday. The company has a quick ratio of 5.69, a current ratio of 6.91 and a debt-to-equity ratio of 0.03. SenesTech has a one year low of $0.52 and a one year high of $15.00. The business’s fifty day moving average price is $0.71 and its 200-day moving average price is $0.83.

SenesTech (NASDAQ:SNES) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). The business had revenue of $0.42 million for the quarter, compared to analysts’ expectations of $0.43 million. SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. During the same quarter in the previous year, the company posted ($15.85) earnings per share. On average, research analysts anticipate that SenesTech will post -1.1 EPS for the current year.

Hedge Funds Weigh In On SenesTech

An institutional investor recently bought a new position in SenesTech stock. Armistice Capital LLC acquired a new position in shares of SenesTech, Inc. (NASDAQ:SNES) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned about 1.94% of SenesTech as of its most recent filing with the Securities and Exchange Commission. 5.19% of the stock is owned by institutional investors.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.